Skip to content

HemosIL LMW Heparin Controls 00020300200Recalls & reported problems

Instrumentation Laboratory Company · HemosIL LMW Heparin Controls · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
0
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Feb 3, 2025Class IIOpen, Classified

    Multiple complaints indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range when testing is performed with HemosIL Liquid Anti-Xa and HemosIL Heparin Calibrator. In some complaints, failure to pass QC resulted in patient testing delays.

    Z-2323-2025 · Root cause: Process control · Recall details · FDA record ↗

Other ASSAY, HEPARIN devices

All ASSAY, HEPARIN devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page